C71T
CANCELLED SECTION 71
04/03/2026
Back to search
Official data from USPTO
MEDONCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/28/2026
Trademark type
Combined
Nice classes
5, 10, 30, 32
Filing date
12/11/2017
Registration date
09/17/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/03/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
CN
Examiner
FLETCHER, TRACY L
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MEDONCARE" with the letter "O" featuring crosshairs.
Holders and representatives
Holders
Medoncare Pharmaceutical Co.,Ltd.
Representatives
ADVANCE CHINA IP LAW OFFICE
Technical classification
Nice Classes
Class 5Class 10Class 30Class 32
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal tonics for the treatment of cancerprostatitisbenign prostatic hyperplasiaAlzheimer's diseaserheumatoid arthritisbone injury diseasesthyroid nodulesdiabetesHBVHIVfatty liver diseasealcoholic liver disease; medicines for human purposes for the treatment of cancerprostatitisbenign prostatic hyperplasiaAlzheimer's diseaserheumatoid arthritisbone injury diseasesthyroid nodulesdiabetesHBVHIVfatty liver diseasealcoholic liver disease; medicinal drinks; capsules for medicines sold empty; pharmaceutical preparations for the treatment of gastrointestinal diseaseskin diseasecardiovascular diseasegoutasthmanasitisprostatic cancerleukemiamelanomabrain gliomacolon cancercervical cancerthyroid cancerkidney cancerstomach cancer and lung cancerhepatitis Bhepatitis CAIDS and influenzaprostatitisbenign prostatic hyperplasia and gynecological inflammationdiabetessleep disorder and rheumatoid arthritis; chemical-pharmaceutical preparations for the treatment of cancerprostatitisbenign prostatic hyperplasiaAlzheimer's diseaserheumatoid arthritisbone injury diseasesthyroid nodulesdiabetesHBVHIVfatty liver diseasealcoholic liver disease; pre-filled syringes for medical purposes for the treatment of cancerasthmainsomnia; medicated lozenges for pharmaceutical purposes; traditional Chinese medicines in the nature of medicinal herbs
Class 10
Urological surgical apparatus and instruments; medical sprayers for cleaning gums and teeth used in dentists' offices during dental procedures; aerosol masks for medical purposes; apparatus for use in medical analysisstethoscopes and X-ray CT scanners; testing apparatus for medical purposessurgical microscopes and X-ray CT scanners; massage apparatus; medical apparatus and instrumentsstethoscopes and X-ray CT scanners; receptacles for applying medicinesinsulin injectors sold empty and implantable subcutaneous drug delivery devices sold empty; vibromassage apparatus; fumigation apparatus for medical purposes
Class 30
Pastries; condimentschutneyminced garlicprepared horseradish; béchamel sauce; food leavening agents; food flavorings being non-essential oils; vanilla flavorings for food or beverages; vegetal preparations for use as coffee substitutes; tea; tea-based beverages; natural sweeteners
Class 32
Non-alcoholic beveragesfruit drinkssoda popdrinking water; isotonic beverages; vegetable beverages
Publications
History of USPTO decisions and trademark events.
35 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/07/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/31/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/13/2020
FIMP
FINAL DISPOSITION PROCESSED
01/13/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/17/2019
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/17/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/04/2019
PUBO
PUBLISHED FOR OPPOSITION
07/02/2019
GPNX
NOTIFICATION PROCESSED BY IB
06/28/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/12/2019
NPUB
NOTICE OF PUBLICATION
06/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/23/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/23/2019
CNFR
FINAL REFUSAL MAILED
02/14/2019
CNFR
FINAL REFUSAL WRITTEN
02/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2019
ALIE
ASSIGNED TO LIE
02/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/07/2018
RFNT
REFUSAL PROCESSED BY IB
08/18/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2018
RFRR
REFUSAL PROCESSED BY MPU
08/02/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/18/2018
CNRT
NON-FINAL ACTION WRITTEN
07/17/2018
MAFR
APPLICATION FILING RECEIPT MAILED
07/17/2018
DOCK
ASSIGNED TO EXAMINER
07/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/13/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/12/2018
Continuous trademark protection
Get notified about every new filing that threatens MEDONCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.